基金业绩
基金费率
投资组合
- 十大重仓股
- 持仓重大变化
- 全部持股
- 持有债券
- 资产配置
基金概况
财务数据
广发中证香港创新药(QDII-ETF)(513120)
2025-12-31
1.2017
-1.4030%
| 变动日期 |
总份额 |
较上期增减 |
较成立时增减 |
| 2025-09-30 | 1,621,913.54 | 437,050.00 | 1,591,900.00 |
| 2025-06-30 | 1,184,863.54 | 46,350.00 | 1,154,850.00 |
| 2025-03-31 | 1,138,513.54 | 46,450.00 | 1,108,500.00 |
| 2024-12-31 | 1,092,063.54 | 245,000.00 | 1,062,050.00 |
| 2024-09-30 | 847,063.54 | 16,200.00 | 817,050.00 |
| 2024-06-30 | 830,863.54 | -80,500.00 | 800,850.00 |
| 2024-03-31 | 911,363.54 | 62,500.00 | 881,350.00 |
| 2023-12-31 | 848,863.54 | 334,550.00 | 818,850.00 |
| 2023-09-30 | 514,313.54 | 200,850.00 | 484,300.00 |
| 2023-06-30 | 313,463.54 | 255,000.00 | 283,450.00 |
| 2023-03-31 | 58,463.54 | 39,700.00 | 28,450.00 |
| 2022-12-31 | 18,763.54 | 4,100.00 | -11,250.00 |
| 2022-09-30 | 14,663.54 | -15,350.00 | -15,350.00 |
| 2022-07-01 | 30,013.54 | -- | -- |
